The global artificial tears market is expected to register a valuation of US$ 3.4 billion in 2024 and further expand at a CAGR of 5.4% to reach a valuation of US$ 5.8 billion by 2034. According to Future Market Insights, glycerine tears are leading the market with a share of about 26.7% in 2024 within the global artificial tears market size.
| Data Points | Market Insights |
|---|---|
| Artificial Tears Market Value 2023 | US$ 3.3 billion |
| Artificial Tears Market Value 2024 | US$ 3.4 billion |
| Artificial Tears Market Value 2034 | US$ 5.8 billion |
| Artificial Tears Market CAGR | 5.4% |
Artificial tears eye drops keep the outer layer of the eyes wet. The market for artificial tears has experienced substantial growth due to the increasing need for greasing eye products in ophthalmic therapy. An increasing percentage of people suffer from dry eye syndrome, which might open up lucrative new markets for artificial tears.
Artificial tears are used to moisten contact lenses, examinations, and routine eye check-ups. The market is expanding due to the rise in eye and post-eye surgeries
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The artificial tears market is exponentially growing due to government initiatives and awareness of dry eye syndrome. Rising rates of dry eye disease and the geriatric population fuel the market's expansion
The National Programme for Control of Blindness (NPCB) and other government programs are increasing public awareness through pharmaceuticals and distribution networks. Furthermore, the need for eye care products and the availability of eye drops to treat eye disease is likely to boost the artificial tears market online.
Artificial tear brands in the global market for artificial tears are competing for market share by acquiring local and small manufacturing. Manufacturers are implementing advertising and social media initiatives to increase the company's sales and market share to promote their products in the marketplace.
Product safety concerns that result in restricting the use of artificial tears products. Additionally, some safety issues with teardrops include the risk of contamination and unfavorable reactions to the preservatives used in the product. The usage is restricted due to safety concerns, and the various eye-related conditions may lead to reduced productivity, negatively influencing the quality of life.
The adverse effects such as eye irritation, eye pain, blurred vision, red eyes, and foreign body sensation in the eyes are undoubtedly challenging the market's expansion. Furthermore, the need for artificial tears is being constrained by developing several drugs that can reduce the irritation caused by dry eye syndrome. Certain restrictions are anticipated to lead to reduced demand for artificial tears, which would, in turn, limit artificial tears market expansion.
Principal Consultant
The sale of artificial tears expanded at a CAGR of 5.0% from 2019 to 2023, owing to the rising dry eye syndrome and increasing pollution rate.
Artificial tears are lubricant eye drops used to reduce the dryness and irritation caused by keratoconjunctivitis sicca. These products, also known as ocular lubricants, are built explicitly to irritate and relieve burning and discomfort caused by dry eyes. Long-term computer use, fatigue, dry and smoky weather, and other reasons can all contribute to dry eyes.
The Dry Eye Directory represents statistics; currently, dry eyes affect between 16 and 49 million Americans. It means 5 to 15% of the total population, and according to a Gallup Poll, 29 million Americans are likely to suffer from dry eye disease by 2034.
The sales of artificial tears in the market are expected to rise during the forecast period due to excessive eye drops and lubrication demand. With the abovementioned factors, the global market is expected to grow 5.4% during the forecast period.
| Country/region | CAGR (2024 to 2034) |
|---|---|
| United States | 6.7% |
| China | 10.2% |
| India | 4.7% |
The United States is estimated to hold a CAGR of 6.7% of the global market through 2034. The United States artificial tears market currently sees several pharmaceutical manufacturers collaborating with eye care solution providers to deliver high-quality products for commercial use.
To increase the impact of manufacturing position on the global market, the industry's players are concentrating on promoting their brands and consolidating supply chain distribution networks in the United States.
India is set to exhibit a growth rate of nearly 4.7% ;in the artificial tears market through 2034. In India, cases of dry eye syndrome are increasing rapidly. For instance, in July 2020, a report published by the Indian Journal of Ophthalmology, a study from north India estimated that dry eye disease (DED) is 32% in north India, and 81% of cases were classified as severe DED based on symptoms.
Growing Prevalence of Eye Disorders Upsurge China Artificial Tears Market
China is likely to secure a 10.2% CAGR in the global artificial tears market by 2034, owing to the prevalence of dryness in the eyes and ocular surface irritation
One of the world's rapidly growing aging populations is in China. For instance, records stated by the World Health Organization (WHO), By 2040, it is anticipated that 28% of China's population will be over 60. A significant increase in the country's senior population has led to China experiencing substantial growth in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Glycerine tears are expected to present a growth of 4.5% by the end of the forecast period, with a market share value of 26.4% by the end of 2024. Glycerine tears help to decrease symptoms of dry eyes, keep the eye moist, and help to protect the eye from injury.
| Product Type | Glycerine |
|---|---|
| CAGR (2024 to 2034) | 4.5% |
Solutions hold an artificial tears market share of 29.2% in 2024 and are expected to grow gradually over the forecast period, with an estimated CAGR of ;5.0%. Generally, artificial tear solutions help maintain moisture and lubricate dry eyes on the outer surfaces of the eyes. These eye drops can be used to treat aging-related dry eyes.
| Dosage Form | Solution |
|---|---|
| CAGR (2024 to 2034) | 5.0% |
Non-preservative-based formulation holds a prominent market share value of 55.2% in 2024, a CAGR of 5.6% by the end of the forecast period. Non-preservative eye drops do not contain any preservatives to stop the growth of bacteria. Non-preservative eye drops are available for three days (inpatients) or seven days (outpatients) in various application containers.
| Formulation | Non-preservative-based Formulation |
|---|---|
| CAGR (2024 to 2034) | 5.6% |
Dry eye syndrome holds a market share of 34.2% in 2024 and is expected to display gradual growth over the forecast period, with an estimated CAGR of 5.4% in 2034. Dry eye syndrome is caused due to autoimmune disease, hormone changes, allergic eye disease, or inflamed eyelid glands. Increased tear evaporation or decreased tear production caused by dry eyes syndrome holds a prominent position in the indication segment of the artificial tear market.
| Indication | Dry Eye Syndrome |
|---|---|
| CAGR (2024 to 2034) | 5.4% |
Retail pharmacies hold a prominent market share value of 38.0% in 2024, with a CAGR of 4.6% through 2034. Retail pharmacy stores have various products of different brands and can be easily located near residential areas, hence gaining a prominent position in the artificial tears market.
| Distribution Channel | Retail Pharmacies |
|---|---|
| CAGR (2024 to 2034) | 4.6% |
The market for producing artificial tears is fragmented, with several competitors. These businesses employ collaborations, partnerships, mergers and acquisitions, and new product releases to satisfy consumer demand and increase their client base. Various key players are launching types of artificial tears eye drops to upsurge the global artificial tears market size.
Recent Developments in the Artificial Tears Market
| Attribute | Details |
|---|---|
| Forecast Period | 2019 to 2023 |
| Historical Data Available for | 2024 to 2034 |
| Market Analysis | US$ billion for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa |
| Key Market Segments Covered | Ingredients, Dosage Form, Route of Administration, Indication, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global artificial tears market is worth US$ 3.4 billion in 2024 and is set to expand 1.7X over the next ten years.
Rising awareness about dry eye syndrome and adoption rate of artificial tears.
The United States, China, and the United Kingdom are expected to drive demand for the artificial tears market.
The artificial tears market is expected to reach a sales revenue to register a 5.4% CAGR.
The United States, India, and China are the key producers of artificial tears.
The United States accounted for a CAGR of 6.7% in the artificial tears market through 2034.
From 2019 to 2023, the market for artificial tears expanded by 5.0%.
India accounts for a CAGR of 4.7% in the global market during the forecast period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. New Product Launches
4.3. PESTEL Analysis
4.4. Porter’s Analysis
4.5. Product Features/ USPs
4.6. Key Promotional Strategies, By Key Manufacturers
4.7. Regulatory Landscape
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Eye Drops and Lubricants Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Market Consolidation Activities
5.2.3. Adoption of New Artificial Tears
5.2.4. Rising Prevalence of Ophthalmic Treatment
5.2.5. Launch of Newly Formulated Product
5.2.6. Rising Ageing Population
5.2.7. Regulatory Imposition
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Demand Value or Size (in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
6.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Product, 2017 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2023 to 2033
7.3.1. Glycerin Tears
7.3.2. Cellulose Tears
7.3.3. Oil-based Emulsion Tears
7.3.4. Polyethylene Glycol Based Tears
7.3.5. Sodium Hyaluronate Based Artificial Tears
7.3.6. Propylene Glycol Based Tears
7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Dosage Form
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) By Dosage Form, 2017 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Dosage Form, 2023 to 2033
8.3.1. Solution
8.3.2. Ointment
8.3.3. Emulsion
8.3.4. Gel
8.3.5. Spray
8.3.6. Suspensions
8.4. Market Attractiveness Analysis By Dosage Form
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Formulation
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Formulation, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Formulation, 2023 to 2033
9.3.1. Preservative Based
9.3.2. Non-Preservative Based
9.4. Market Attractiveness Analysis By Formulation
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Indication, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033
10.3.1. Dry Eye Syndrome
10.3.2. Allergies
10.3.3. Infections
10.3.4. UV & Blue Light Protection
10.3.5. Contact Lens Moisture Retention
10.3.6. Others
10.4. Market Attractiveness Analysis By Indication
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) By Distribution Channel, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
11.3.1. Retail Pharmacies
11.3.2. Hospital Pharmacies
11.3.3. Online Pharmacies
11.3.4. Ophthalmic Stores
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis by Region, 2017 to 2022
12.3. Current Market Size (US$ Million) Analysis and Forecast by Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Dosage Form
13.3.4. By Formulation
13.3.5. By Indication
13.3.6. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Dosage Form
13.4.4. By Formulation
13.4.5. By Indication
13.4.6. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. USA Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Dosage Form
13.8.1.2.3. By Formulation
13.8.1.2.4. By Indication
13.8.1.2.5. By Distribution Channel
13.8.2. Canada Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Dosage Form
13.8.2.2.3. By Formulation
13.8.2.2.4. By Indication
13.8.2.2.5. By Distribution Channel
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Mexico
14.3.1.2. Brazil
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By Dosage Form
14.3.4. By Formulation
14.3.5. By Indication
14.3.6. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Dosage Form
14.4.4. By Formulation
14.4.5. By Indication
14.4.6. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Mexico Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Dosage Form
14.8.1.2.3. By Formulation
14.8.1.2.4. By Indication
14.8.1.2.5. By Distribution Channel
14.8.2. Brazil Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Dosage Form
14.8.2.2.3. By Formulation
14.8.2.2.4. By Indication
14.8.2.2.5. By Distribution Channel
14.8.3. Argentina Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Dosage Form
14.8.3.2.3. By Formulation
14.8.3.2.4. By Indication
14.8.3.2.5. By Distribution Channel
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. UK
15.3.1.2. Germany
15.3.1.3. Italy
15.3.1.4. France
15.3.1.5. Spain
15.3.1.6. Russia
15.3.1.7. BENELUX
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Dosage Form
15.3.4. By Formulation
15.3.5. By Indication
15.3.6. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Dosage Form
15.4.4. By Formulation
15.4.5. By Indication
15.4.6. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. UK. Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Dosage Form
15.8.1.2.3. By Formulation
15.8.1.2.4. By Indication
15.8.1.2.5. By Distribution Channel
15.8.2. Germany Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Dosage Form
15.8.2.2.3. By Formulation
15.8.2.2.4. By Indication
15.8.2.2.5. By Distribution Channel
15.8.3. Italy Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Dosage Form
15.8.3.2.3. By Formulation
15.8.3.2.4. By Indication
15.8.3.2.5. By Distribution Channel
15.8.4. France Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Dosage Form
15.8.4.2.3. By Formulation
15.8.4.2.4. By Indication
15.8.4.2.5. By Distribution Channel
15.8.5. Spain Market Analysis
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Dosage Form
15.8.5.2.3. By Formulation
15.8.5.2.4. By Indication
15.8.5.2.5. By Distribution Channel
15.8.6. Russia Market Analysis
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Dosage Form
15.8.6.2.3. By Formulation
15.8.6.2.4. By Indication
15.8.6.2.5. By Distribution Channel
15.8.7. BENELUX Market Analysis
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Dosage Form
15.8.7.2.3. By Formulation
15.8.7.2.4. By Indication
15.8.7.2.5. By Distribution Channel
16. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Dosage Form
16.3.4. By Formulation
16.3.5. By Indication
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Dosage Form
16.4.4. By Formulation
16.4.5. By Indication
16.4.6. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. China Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Dosage Form
16.8.1.2.3. By Formulation
16.8.1.2.4. By Indication
16.8.1.2.5. By Distribution Channel
16.8.2. Japan Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Dosage Form
16.8.2.2.3. By Formulation
16.8.2.2.4. By Indication
16.8.2.2.5. By Distribution Channel
16.8.3. South Korea Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Dosage Form
16.8.3.2.3. By Formulation
16.8.3.2.4. By Indication
16.8.3.2.5. By Distribution Channel
17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Indonesia
17.3.1.3. Malaysia
17.3.1.4. Thailand
17.3.1.5. Rest of South Asia
17.3.2. By Product
17.3.3. By Dosage Form
17.3.4. By Formulation
17.3.5. By Indication
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Dosage Form
17.4.4. By Formulation
17.4.5. By Indication
17.4.6. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. India Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Dosage Form
17.8.1.2.3. By Formulation
17.8.1.2.4. By Indication
17.8.1.2.5. By Distribution Channel
17.8.2. Indonesia Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Dosage Form
17.8.2.2.3. By Formulation
17.8.2.2.4. By Indication
17.8.2.2.5. By Distribution Channel
17.8.3. Malaysia Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Dosage Form
17.8.3.2.3. By Formulation
17.8.3.2.4. By Indication
17.8.3.2.5. By Distribution Channel
17.8.4. Thailand Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Dosage Form
17.8.4.2.3. By Formulation
17.8.4.2.4. By Indication
17.8.4.2.5. By Distribution Channel
18. Oceania Market 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Dosage Form
18.3.4. By Formulation
18.3.5. By Indication
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Dosage Form
18.4.4. By Formulation
18.4.5. By Indication
18.4.6. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Dosage Form
18.8.1.2.3. By Formulation
18.8.1.2.4. By Indication
18.8.1.2.5. By Distribution Channel
18.8.2. New Zealand Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Dosage Form
18.8.2.2.3. By Formulation
18.8.2.2.4. By Indication
18.8.2.2.5. By Distribution Channel
19. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
19.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Dosage Form
19.3.4. By Formulation
19.3.5. By Indication
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Dosage Form
19.4.4. By Formulation
19.4.5. By Indication
19.4.6. By Distribution Channel
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Dosage Form
19.8.1.2.3. By Formulation
19.8.1.2.4. By Indication
19.8.1.2.5. By Distribution Channel
19.8.2. Türkiye Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Dosage Form
19.8.2.2.3. By Formulation
19.8.2.2.4. By Indication
19.8.2.2.5. By Distribution Channel
19.8.3. South Africa Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Dosage Form
19.8.3.2.3. By Formulation
19.8.3.2.4. By Indication
19.8.3.2.5. By Distribution Channel
19.8.4. North Africa Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Dosage Form
19.8.4.2.3. By Formulation
19.8.4.2.4. By Indication
19.8.4.2.5. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
20.3.1. By Regional Footprint of Players
20.3.2. Product Footprint of Players
20.3.3. Channel Footprint of Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1.1. AbbVie, Inc.
21.3.1.2. Overview
21.3.1.3. Product & Services Portfolio
21.3.1.4. Key Financials
21.3.1.5. SWOT Analysis
21.3.1.6. Key Developments
21.3.1.7. Sales Footprint
21.3.1.8. Strategy Overview
21.3.1.8.1. Marketing Strategy
21.3.1.8.2. Product Strategy
21.3.1.8.3. Channel Strategy
21.3.2. Akorn, Inc.
21.3.3. Alcon
21.3.4. Bausch & Lomb
21.3.5. Johnson & Johnson
21.3.6. Eyevance Pharmaceuticals LLC
21.3.7. Ocusoft
21.3.8. I- MED PHARMA
21.3.9. Santen Pharmaceutical Co. Ltd
21.3.10. Similasan Corporation
21.3.11. Sun Pharmaceutical Industries Ltd
21.3.12. Ursapharm Arzneimittel GmbH
21.3.13. Novartis International AG
21.3.14. AFT Pharmaceuticals
21.3.15. Allergan plc
21.3.16. Rohto Pharmaceutical Co., Ltd
21.3.17. VISUfarma
21.3.18. Otsuka Pharmaceutical Co., Ltd.
21.3.19. NovaMedica LLC
21.3.20. ENTOD Research Cell UK Ltd
21.3.21. OASIS Medical, Inc
21.3.22. Abbott Medical Optics Inc
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Artificial Tears Market
